Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (October 2025)

Pharma stocks eye best week in 16 years as Trump overhang eases

The advance was spurred by Pfizer when it agreed to slash some of its drug prices for Americans enrolled in Medicaid. Read more at straitstimes.com.

Atlantic Magazine Praises Trump for Forcing Pfizer to Slash Drug Prices

Atlantic Magazine Praises Trump for Forcing Pfizer to Slash Drug Prices It was grudging praise for President Donald Trump yet considering the source it was surprising bordering on astounding praise. Atlantic magazine writer Nicholas Florko should therefore be put on the alert to prepare for his shunning by his colleagues and other members of the media for daring to give what is in effect high praise to Trump for forcing Pfizer to agree to slash…

Pfizer – TrumpRx deal boosts Big Pharma stocks (PFE:NYSE)

The biggest pharma stocks in the world posted record gains this week, as Pfizer (NYSE:PFE) reached a landmark drug pricing deal with the U.S. Read more here.

Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (October 2025)

Shares of Pfizer (NYSE: PFE) gained 10.02% over the past month after gaining 4.50% the month prior. The stock’s year-to-date gain now stands at 2.50%. Over the past year, PFE has fallen by 3.76%. The recent rally in the Big Pharma stock can be attributed to the Trump administration announcing a plan for TrumpRx, which seeks to lower prescription costs for Americans, with Pfizer working in partnership with the federal government. This summer, the…

Another Drug Pricing Demo Surfaces After Trump-Pfizer Deal

Jeffrey Davis reacted to the emergence of a new CMS drug pricing demo following the Trump-Pfizer deal, noting the lack of transparency around the model raises concerns about stakeholder input and policy direction, in Inside Health Policy. READ MORE The post Another Drug Pricing Demo Surfaces After Trump-Pfizer Deal appeared first on McDermott+.